IL129762A0 - Novel macromolecules methods for their preparation pharmaceutical compositions thereof and their use as anti-influenza agents - Google Patents

Novel macromolecules methods for their preparation pharmaceutical compositions thereof and their use as anti-influenza agents

Info

Publication number
IL129762A0
IL129762A0 IL12976297A IL12976297A IL129762A0 IL 129762 A0 IL129762 A0 IL 129762A0 IL 12976297 A IL12976297 A IL 12976297A IL 12976297 A IL12976297 A IL 12976297A IL 129762 A0 IL129762 A0 IL 129762A0
Authority
IL
Israel
Prior art keywords
methods
pharmaceutical compositions
preparation pharmaceutical
influenza agents
novel macromolecules
Prior art date
Application number
IL12976297A
Other languages
English (en)
Original Assignee
Biota Scient Management
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO3632A external-priority patent/AUPO363296A0/en
Priority claimed from AUPO8539A external-priority patent/AUPO853997A0/en
Application filed by Biota Scient Management filed Critical Biota Scient Management
Publication of IL129762A0 publication Critical patent/IL129762A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12976297A 1996-11-14 1997-11-13 Novel macromolecules methods for their preparation pharmaceutical compositions thereof and their use as anti-influenza agents IL129762A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO3632A AUPO363296A0 (en) 1996-11-14 1996-11-14 Method and novel compounds for use therein
AUPO8539A AUPO853997A0 (en) 1997-08-14 1997-08-14 Method and novel compounds for use therein
PCT/AU1997/000771 WO1998021243A1 (fr) 1996-11-14 1997-11-13 Methode et nouveaux composes a utiliser avec ladite methode

Publications (1)

Publication Number Publication Date
IL129762A0 true IL129762A0 (en) 2000-02-29

Family

ID=25645315

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12976297A IL129762A0 (en) 1996-11-14 1997-11-13 Novel macromolecules methods for their preparation pharmaceutical compositions thereof and their use as anti-influenza agents

Country Status (19)

Country Link
US (1) US6680054B1 (fr)
EP (1) EP0951480A4 (fr)
JP (1) JP3691075B2 (fr)
KR (1) KR20000068986A (fr)
CN (1) CN1238783A (fr)
AP (1) AP9901531A0 (fr)
AU (1) AU732916C (fr)
BR (1) BR9714299A (fr)
CA (1) CA2271249C (fr)
CZ (1) CZ167999A3 (fr)
EA (1) EA001603B1 (fr)
HU (1) HUP9904009A3 (fr)
IL (1) IL129762A0 (fr)
IS (1) IS5044A (fr)
NO (1) NO992297L (fr)
NZ (1) NZ335368A (fr)
PL (1) PL333364A1 (fr)
TR (1) TR199901081T2 (fr)
WO (1) WO1998021243A1 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US7425541B2 (en) * 1998-12-11 2008-09-16 Medarex, Inc. Enzyme-cleavable prodrug compounds
AUPP913999A0 (en) 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
AUPR001000A0 (en) * 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US20030068655A1 (en) * 2001-09-12 2003-04-10 Protiveris, Inc. Microcantilever apparatus and methods for detection of enzymes
AUPR879401A0 (en) 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
JP2008531764A (ja) 2005-02-23 2008-08-14 リポクセン テクノロジーズ リミテッド タンパク質の誘導体化及び結合のための活性化シアル酸誘導体
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
KR101660363B1 (ko) * 2007-06-25 2016-09-28 더 어드미니스트레이터즈 오브 더 튜래인 어듀케이셔널 훤드 인플루엔자를 억제하는 조성물 및 방법
US8999954B2 (en) * 2007-07-03 2015-04-07 Childern's Hospital & Research Center at Oakland Inhibitors of polysialic acid de-N-acetylase and methods for using the same
WO2009006620A1 (fr) 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Dérivés d'acide oligosialique, procédés de fabrication et utilisations immunologiques
AU2008272785B2 (en) * 2007-07-03 2014-06-12 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
US20130280204A1 (en) * 2007-08-27 2013-10-24 Massachusetts Institute Of Technology Polymer-Attached Inhibitors of Influenza Virus
US20090076133A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched zanamivir
JP5986745B2 (ja) 2008-07-15 2016-09-06 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ Ｐｔｆｅ様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
CA2762022A1 (fr) 2009-05-15 2010-11-18 Redx Pharma Limited Derives redox de medicaments
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (fr) 2010-04-12 2011-10-20 Academia Sinica Puces au glycane pour la recherche par criblage haut débit de virus
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
PL225045B1 (pl) 2012-05-18 2017-02-28 Univ Jagiellonski Zastosowanie polimeru chitozanowego do wytwarzania leków do leczenia i profilaktyki infekcji wywołanych przez koronawirusy
WO2014031498A1 (fr) 2012-08-18 2014-02-27 Academia Sinica Sondes perméables aux cellules pour l'identification et l'imagerie de sialidases
WO2014152946A2 (fr) 2013-03-14 2014-09-25 University Of Washington Through Its Center For Commercialization Polypeptides pour le traitement et/ou la limitation d'une infection grippale
KR102348484B1 (ko) 2013-04-01 2022-01-07 벡톤 디킨슨 앤드 컴퍼니 인플루엔자의 진단을 위한 방법 및 키트
US10086054B2 (en) 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
WO2014210564A1 (fr) 2013-06-27 2014-12-31 Academia Sinica Conjugués de glycane et leur utilisation
JP6486368B2 (ja) 2013-09-06 2019-03-20 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 改変されたグリコシル基を含む糖脂質を用いたヒトｉＮＫＴ細胞の活性化
TW201620939A (zh) 2014-01-16 2016-06-16 中央研究院 治療及檢測癌症之組合物及方法
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
EP3129767B1 (fr) 2014-03-27 2021-09-01 Academia Sinica Composés de marquage réactifs et leurs utilisations
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
AU2015267045B2 (en) 2014-05-27 2021-02-25 Academia Sinica Anti-HER2 glycoantibodies and uses thereof
DK3149045T3 (da) 2014-05-27 2023-03-06 Academia Sinica Sammensætninger og fremgangsmåder vedrørende universelle glycoformer til forbedret antistofeffekt
KR20170003720A (ko) 2014-05-27 2017-01-09 아카데미아 시니카 항-ｃｄ20 글리코항체 및 이의 용도
JP7063538B2 (ja) 2014-05-28 2022-05-09 アカデミア シニカ 抗ＴＮＦα糖操作抗体群およびその使用
EP3191500A4 (fr) 2014-09-08 2018-04-11 Academia Sinica Activation des cellules inkt humaines par des glycolipides
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10342858B2 (en) 2015-01-24 2019-07-09 Academia Sinica Glycan conjugates and methods of use thereof
AU2016356726C1 (en) 2015-11-20 2021-12-09 AusVir Therapeutics Pty Ltd Compounds for medicinal applications
AU2017231749A1 (en) 2016-03-08 2018-09-20 Academia Sinica Methods for modular synthesis of N-glycans and arrays thereof
AU2017316663B2 (en) 2016-08-22 2024-02-22 CHO Pharma Inc. Antibodies, binding fragments, and methods of use
WO2020051498A1 (fr) 2018-09-06 2020-03-12 Cidara Therapeutics, Inc. Compositions et procédés pour le traitement d'infections virales
TWI861205B (zh) 2019-09-06 2024-11-11 美商席達拉醫療有限公司 用於治療病毒感染之組合物及方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ288492B6 (en) * 1990-04-24 2001-06-13 Biota Scient Management Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
US5221611A (en) 1991-06-19 1993-06-22 Sigma Chemical Company Ddi immunoassays, derivatives, conjugates and antibodies
CA2081068C (fr) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Derives antiviraux de 2-desoxy-2,3-deshydro a substituant en 4 de l'acide .alpha.-d-neuraminique
WO1994011005A1 (fr) 1992-11-09 1994-05-26 Scientific Dimensions Usa, Inc. Inhibiteurs de fixation virale
US5681811A (en) 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
GB9410817D0 (en) 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
US5952375A (en) * 1995-02-27 1999-09-14 Gilead Sciences, Inc. Compounds and methods for synthesis and therapy
GB9516276D0 (en) 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
IL125662A0 (en) * 1996-03-01 1999-04-11 Biota Scient Management Method of detecting influenza virus and compounds for use therein
AUPO104396A0 (en) 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Antiviral linear polymers
AUPP913999A0 (en) * 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use

Also Published As

Publication number Publication date
KR20000068986A (ko) 2000-11-25
EA199900459A1 (ru) 1999-12-29
CZ167999A3 (cs) 1999-10-13
US6680054B1 (en) 2004-01-20
CA2271249C (fr) 2010-07-20
CN1238783A (zh) 1999-12-15
EP0951480A4 (fr) 2004-07-28
IS5044A (is) 1999-04-30
JP2001504876A (ja) 2001-04-10
TR199901081T2 (xx) 1999-08-23
NO992297L (no) 1999-07-12
AU732916B2 (en) 2001-05-03
NO992297D0 (no) 1999-05-12
BR9714299A (pt) 2000-04-25
HUP9904009A2 (hu) 2000-03-28
EP0951480A1 (fr) 1999-10-27
WO1998021243A1 (fr) 1998-05-22
AP9901531A0 (en) 1999-05-13
EA001603B1 (ru) 2001-06-25
CA2271249A1 (fr) 1998-05-22
AU732916C (en) 2002-06-06
PL333364A1 (en) 1999-12-06
AU4857697A (en) 1998-06-03
HUP9904009A3 (en) 2001-07-30
NZ335368A (en) 2001-08-31
JP3691075B2 (ja) 2005-08-31

Similar Documents

Publication Publication Date Title
IL114578A0 (en) Amino purine-béta-D ribofuranuronamide derivatives their preparation pharmaceutical compositions containing them and their use
HUP9900605A3 (en) Lipopolyamines as transfection agents, preparation and use thereof and pharmaceutical compositions containing them
IL123986A0 (en) Antithombotic agents process for their preparation and pharmaceutical compositions comprising them
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
ITMI950529A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
IL127798A (en) N-substituted indol-3-glyoxylamides, process for their preparation and pharmaceutical compositions comprising them
ZA9510146B (en) Novel perhydroisoindole derivatives processes for their preparation and pharmaceutical compositions comprising them
HUP0101130A3 (en) Aminoindan derivatives and pharmaceutical compositions comprising them
IL120141A (en) Substituted quinazoline derivatives process for their preparation and pharmaceutical compositions containing them
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
HUP0000426A3 (en) Novel benzonaphthyridines, pharmaceutical compositions and use thereof and process for their preparation
IL114492A0 (en) Benzimidazole derivatives their preparation and pharmaceutical compositions containing them
ZA968322B (en) Solid sillicone compositions and methods for their preparation and use
IL117349A0 (en) N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them
IL115905A0 (en) Sordarin derivatives their preparation and pharmaceutical compositions containing them
IL125710A0 (en) Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them
HUP0002404A3 (en) Amino acid derivatives, pharmaceutical compositions comprising thereof, process for preparation them and their use
IL115072A0 (en) Substituted 4-phenyl-6-amino-nicotinic acid derivatives their preparation pharmaceutical compositions containing them and their use
HU9503624D0 (en) Use of p antagonist in pharmaceutical compositions
IL124779A0 (en) Novel benzoylguanidine derivatives processes for preparing them and their use in the preparation of pharmaceutical compositions
HUP9904027A3 (en) Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases
IL123900A0 (en) New phenylamidine derivatives processes for preparing them and their use as pharmaceutical compositions
IL115027A (en) N-substituted phenothiazines their preparation pharmaceutical compositions containing them and their use
IL117495A0 (en) Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same